Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Both sides next revision |
influenza [2022/04/02 14:25]
mathew | influenza [2022/05/10 07:23] (current)
liam [Flu Drugs] |
|---|
| |
| ===== Flu Drugs ===== | ===== Flu Drugs ===== |
| In 2018, Japanese pharmaceutical company [[pharmaceutical companies:Shionogi & Co.]] developed a drug called Xofluza (baloxavir marboxil) that they say kills influenza virus in 24 hours.((February 10, 2022 | [[Wall Street Journal]] | archived | [[https://web.archive.org/web/20200611173456/https://www.wsj.com/articles/experimental-drug-promises-to-kill-the-flu-virus-in-a-day-1518264004|Experimental Drug Promises to Kill the Flu Virus in a Day]])) The drug was approved in Japan in early 2018.((February 28, 2018 | [[Fierce Pharma]] | [[https://www.fiercepharma.com/marketing/shionogi-s-flu-drug-oked-japan-but-u-s-approval-not-likely-until-2019-report|Shionogi’s flu drug wins green light in Japan, but U.S. approval not likely until 2019]])) | In 2018, Japanese pharmaceutical company [[pharmaceutical companies:Shionogi|Shionogi & Co.]] developed a drug called Xofluza (baloxavir marboxil) that they say kills influenza virus in 24 hours.((February 10, 2022 | [[Wall Street Journal]] | archived | [[https://web.archive.org/web/20200611173456/https://www.wsj.com/articles/experimental-drug-promises-to-kill-the-flu-virus-in-a-day-1518264004|Experimental Drug Promises to Kill the Flu Virus in a Day]])) The drug was approved in Japan in early 2018.((February 28, 2018 | [[Fierce Pharma]] | [[https://www.fiercepharma.com/marketing/shionogi-s-flu-drug-oked-japan-but-u-s-approval-not-likely-until-2019-report|Shionogi’s flu drug wins green light in Japan, but U.S. approval not likely until 2019]])) |
| |
| ===== Flu Outbreaks by Year ===== | ===== Flu Outbreaks by Year ===== |
